Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-26-033807
Filing Date
2026-07-17
Accepted
2026-07-17 17:30:02
Documents
87

Document Format Files

Seq Description Document Type Size
1 S-1 forms-1.htm   iXBRL S-1 6048343
2 EX-5.1 ex5-1.htm EX-5.1 18784
3 EX-23.1 ex23-1.htm EX-23.1 3687
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 24483
5 GRAPHIC forms-1_001.jpg GRAPHIC 37124
6 GRAPHIC ex5-1_001.jpg GRAPHIC 4255
7 GRAPHIC audit_001.jpg GRAPHIC 30513
  Complete submission text file 0001493152-26-033807.txt   23585631

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ppcb-20260331.xsd EX-101.SCH 90210
9 XBRL CALCULATION FILE ppcb-20260331_cal.xml EX-101.CAL 95605
10 XBRL DEFINITION FILE ppcb-20260331_def.xml EX-101.DEF 519063
11 XBRL LABEL FILE ppcb-20260331_lab.xml EX-101.LAB 724238
12 XBRL PRESENTATION FILE ppcb-20260331_pre.xml EX-101.PRE 618716
91 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 3750968
92 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 4171
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-297554 | Film No.: 261184669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)